CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD) | |
NEONATAL INTRAHEPATIC CHOLESTASIS CAUSED BY CITRIN DEFICIENCY, NICCD | |
605814
OMIM = Online Mendelian Inheritance of Men | |
247598 | |
citrin deficiency, calcium-binding mitochondrial carrier protein Aralar2 | |
7q21.3 |
|
E72.2 | |
rare autosomal recessive mutation in the SLC25A13 gene The profiles of blood amino acid in early neonates with NICCD present the increased levels of multiple amino acids including citrulline, tyrosine, methionine and phenylalanine, and decreased ratio of Ala/Cit [Tang CF 2019] | |
Laboratory findings | Citrulline inc (plasma) D-Galactose normal/inc (plasma) 4-Hydroxyphenyllactic acid inc (urine) Acylcarnitine (C2) inc (blood) alpha-Fetoprotein inc (plasma) Bilirubin inc (serum) D-Galactose inc (urine) L-Carnitine inc (plasma) L-Threonine inc (plasma) L-Tyrosine inc (plasma) Methionine inc (plasma) Palmitoylcarnitine (C16) inc (blood) Phenylalanine inc (dried blood spot (DB) Propionylcarnitine (C3) inc (blood) Protein, total dec (serum) Stearoylcarnitine (C18) inc (blood) Transaminases (ASAT/ALAT) normal/inc (serum) |
Symptoms | cholestasis coma developmental delay encephalopathy jaundice liver involvement or dysfunction ataxia bleeding tendencies, hemorrhages cirrhosis or fibrosis of liver Coagulopathy/Coagulation factors failure to thrive hepatomegaly (large liver) hypoglycemia liver steatosis liver, fatty onset, neonatal |